Search

Your search keyword '"Cüppers A"' showing total 465 results

Search Constraints

Start Over You searched for: Author "Cüppers A" Remove constraint Author: "Cüppers A"
465 results on '"Cüppers A"'

Search Results

1. Succinct Interaction-Aware Explanations

2. Experimental Validation of Memristor-Aided Logic Using 1T1R TaOx RRAM Crossbar Array

3. Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection

4. Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)

7. Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)

8. Intrinsic RESET speed limit of valence change memories

12. Correlation between Electronic Structure, Microstructure, and Switching Mode in Valence Change Mechanism Al2O3/TiOx‐Based Memristive Devices

14. Niemann's Photos from Belzec

20. Acknowledgments

22. Contents

23. Map

25. 7. The Trawnikis: Auxiliaries to the Holocaust

26. Photos from the Niemann Collection, up to 1942

27. Preface

28. Foreword

29. Index

30. Half title, Series information, Title Page, Copyright

33. Sources and Bibliography

35. Henriette Niemann in the Photo Collection

36. The Berlin Album and Additional Travel Pictures

37. 6. The Sobibor Death Camp

40. About the Authors and Editors

41. Appendix 1 . The Brandenburg Album

44. Niemann's photos from Sobibor

45. Appendix 4 . Short Biographies of German Perpetrators

46. Design of materials properties and device performance in memristive systems

47. On the switching dynamics of epitaxial ferroelectric CeO2–HfO2 thin film capacitors

48. NEUROTEC I: Neuro-inspired Artificial Intelligence Technologies for the Electronics of the Future.

49. Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)

50. A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network

Catalog

Books, media, physical & digital resources